Search

everythinglearnresearchcommunity

for

Search:↓

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Different PCOS subgroups have similar metabolic features, but those without menstrual problems have milder issues.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Overweight women with PCOS are more likely to have excess male hormones.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

High BMI worsens hair growth in women with PCOS.

PCOS affects fertility and is linked to obesity and menstrual irregularities; lifestyle changes are recommended for treatment.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Polycystic ovary syndrome (PCOS) is more common in urban areas, possibly due to lifestyle and diet, and ignoring it can lead to serious health issues.